Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06786884 · ClinicalTrials.gov registry record · NA
Paraffin Wax and Exercise Prospective
A NA study of Scar and Burn, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06786884: Recruiting NA study of Scar and Burn, sponsored by Medstar Health Research Institute.
NCT06786884 is a NA study of Scar and Burn that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 30 participants, below the 47-participant average among 15 other Scar trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06786884, a NA study of Scar and Burn, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to test if paraffin wax can be used to improve the range of motion and function for scars across joints when used in combination with scar rehabilitation therapy sessions. For those randomized to receive it, the paraffin wax will be used alongside the participants' exercise therapy treatments. Currently, treatments that are used in addition to rehabilitation therapy for increasing range of motion across joints in the burn population are limited. By getting more information about how paraffin wax may or may not work, patients in the future that have scars may be able to be helped.
Primary Outcome
Range of motion (degrees) of the affected joint before and after paraffin wax between the paraffin and no paraffin groups
Conditions Studied
Interventions
- DEVICE paraffin wax
- DEVICE standard of care exercise therapy
Study Locations (1)
District of Columbia
- MedStar Washington Hosptial Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2027-02 |
| Phase | NA |
What NCT06786884 shows while recruiting
NCT06786884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 47-participant average among 15 other Scar trials with a reported enrollment target (36% lower).
The record links to 3 conditions, with Scar appearing as the primary indexed condition, and to 2 interventions - of which paraffin wax is the first listed.
NCT06786884 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06786884 about?
NCT06786884 is a clinical study titled "Paraffin Wax and Exercise Prospective". This study is being done to test if paraffin wax can be used to improve the range of motion and function for scars across joints when used in combination with scar rehabilitation therapy sessions. For those randomized to receive it, the paraffin wax will be used alongside the participants' exercise ...
What is the current status of trial NCT06786884?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-01-06. Estimated completion is 2027-02.
What conditions does trial NCT06786884 study?
This clinical trial studies the following conditions: Scar, Burn, Exercise Therapy.
What interventions are being tested in trial NCT06786884?
The interventions under investigation include: paraffin wax (DEVICE), standard of care exercise therapy (DEVICE).
Who is sponsoring clinical trial NCT06786884?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06786884 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06786884's enrollment target sits among peer trials
30 8th of 15 higher than 5 of 15 other Scar trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Scar trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Microneedling vs Dermabrasion for Early Facial Scar Resurfacing
RECRUITING · NA
-
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
RECRUITING · NA
-
CO2 Laser Revision for Burn Related Donor Site Scars
ACTIVE NOT RECRUITING · NA
-
Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects
ACTIVE NOT RECRUITING · NA
-
PDL and Fractional Photothermolysis for Postsurgical Scars
ACTIVE NOT RECRUITING · NA
-
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI